Latest news and events

Latest News from the Partnership

Dr. Emma Haapaniemi. Photo: Matti Immonen

2019.04.02 | Research news

Welcome to: Emma Haapaniemi, Group Leader, NCMM

Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.

Keisuke Yonehara. Photo: Annabel Darby
The Yonehara Lab Photo: Annabel Darby

2019.03.29 | Research news

Behind the Scenes: Keisuke Yonehara, Group Leader, DANDRITE

Keisuke Yonehara is head of the Spatially Asymmetric Neural Circuits in Visual System group at DANDRITE. He recently had his group leader position extended for a further four years. In our latest Behind the Scenes article, Dr Yonehara discusses his research and how made the move from veterinary science to neuroscience.

The Chemical Biology Screening team (from left to right - Alexandra Gade, Eirin Solberg, and Johannes Landskron) Photo: Nadia Frantsen

2019.03.15 | News from the management

Behind the Scenes: The Chemical Biology Platform at NCMM

Johannes Landskron, Head of the Chemical Biology Platform at NCMM, shares some insight into how the platform works, and why it is so important for researchers.

Jing Tang (third from left) and the iCombine Team, winners of the Helsinki Challenge. Photo: Jing Tang

2019.03.15 | People , News from the management

Behind the Scenes: Jing Tang, Group Leader, FIMM

Jing Tang joined FIMM as a senior researcher in Tero Aittokallio’s group in 2012. Here he shares some background on his career and research to date.

Image Caption

2019.03.15 | Research news

First common risk genes discovered for autism

An international research team involving scientists from FIMM has found the first common genetic risk variants for autism.

Professor Janna Saarela. Photo: Kirsi Tuura, University of Helsinki

2019.02.08 | People

Welcome to: Professor Janna Saarela

Professor Janna Saarela officially started as Director of NCMM in January 2019. She joins NCMM from the Nordic EMBL's Finnish partner, FIMM. Here she shares some insight into her research, and her vision for the future of NCMM.

2019.01.21 | Research news

GSK and Sanofi join FinnGen study

GSK and Sanofi have joined the FinnGen study, a large public-private partnership aiming to collect and analyse genome and health data from 500 000 Finns and thereby generate novel medically and therapeutically relevant insights.

Linda Sandblad (centre) at the electron microscopy unit at Umeå University. Photo: Mattias Pettersson
3D reconstruction at atomic resolution from about 1000 images of protein complex of human pathogen. Image: Luecke Group

2019.01.02 | Research news

Insight: Cryo-EM and the Nordic EMBL Partnership

Cryo-electron microscopy, or cryo-EM, has been around since the 1970s, but it’s only in recent years that, thanks to technological advances, the technique has become more accessible. We interviewed Nordic EMBL Partnership directors, Poul Nissen, Director of DANDRITE, and Bernt Eric Uhlin, Founding Director of MIMS until October 2018, about the…

Professor Mark Daly. Photo: Veikko Somerpuro

2018.12.14 | People

Welcome to: Professor Mark Daly, newly appointed Director, FIMM

Professor Daly joined FIMM from the Broad Institute of MIT and Harvard and Massachusetts General Hospital. Here he discusses his research and the reasons he chose to move to Finland from the USA

Iain Mattaj. Photo: EMBL/Human Technopole

2018.11.30 | People

New role for Iain Mattaj

The EMBL Director General, who steps down from his role at the end of 2018, has been named as the Director of Human Technopole

Showing results 21 to 30 of 38

Previous 1 2 3 4 Next

Upcoming Partnership Events

News on publications